Cargando…

Comparison of Three Groups of Patients Having Low Dose Rate Prostate Brachytherapy: Prostate-Specific Antigen Failure and Overall Survival

Purpose To examine dosimetric and clinical outcomes for Cs-131 radioactive seed implant compared to Pd-103 and I-125. Background/Significance Cs-131 is a novel isotope with relatively short half-life (9.7 days) that may have clinical advantages in seed implant treatments of prostate cancers. There...

Descripción completa

Detalles Bibliográficos
Autores principales:	Booher, Jacquelyn, Domenig, Peter, Goldman, Benjamin, Campbell, Todd, Verdecchia, Kyle, Boura, Judith A, Chuba, Paul J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Medical Physics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532522/ https://www.ncbi.nlm.nih.gov/pubmed/34707958 http://dx.doi.org/10.7759/cureus.18185

Ejemplares similares

Management of Prostate Cancer During COVID-19 Pandemic: Perspective From Urologists and Radiation Oncologists in COVID Dense Metro Detroit
por: Domenig, Peter, et al.
Publicado: (2020)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

Clinical features of prostate-specific antigen bounce after (125)I brachytherapy for prostate cancer
por: Kubo, Katsumaro, et al.
Publicado: (2018)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017)

Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
por: Mayrata, Esther, et al.
Publicado: (2021)

Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer
por: Hamilton, Andrew J, et al.
Publicado: (2018)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Incorporating Routine Magnetic Resonance Imaging-based Planning for the Delivery of High-dose-rate Brachytherapy for Prostate Cancer: An Evaluation of Clinical Feasibility and Dosimetric Outcomes
por: Saigal, Kunal, et al.
Publicado: (2019)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer
por: Tsumura, Hideyasu, et al.
Publicado: (2016)

Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma
por: Horiguchi, Hiroto, et al.
Publicado: (2014)

Prostate-Specific Antigen Bounce after (125)I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer
por: Kim, Tae Hyung, et al.
Publicado: (2022)

The current role of imaging for prostate brachytherapy
por: Carey, Brendan, et al.
Publicado: (2007)

Photoacoustic imaging of prostate brachytherapy seeds
por: Su, Jimmy L., et al.
Publicado: (2011)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Prostate cancer brachytherapy: guidelines overview
por: Wojcieszek, Piotr, et al.
Publicado: (2012)

Current Status of Brachytherapy for Prostate Cancer
por: Park, Dong Soo
Publicado: (2012)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

Implications of local failure on overall prognosis in aggressive prostate cancer
por: Mula-Hussain, Layth, et al.
Publicado: (2020)

Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer
por: Tribukait, Bernhard, et al.
Publicado: (2023)

Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation
por: Smith, Christopher W., et al.
Publicado: (2021)

Focal low-dose rate brachytherapy for the treatment of prostate cancer
por: Tong, William Y, et al.
Publicado: (2013)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer
por: Nishimura, Shuichi, et al.
Publicado: (2018)

Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?
por: Safdieh, Joseph, et al.
Publicado: (2016)

Results of a Prospective Dose Escalation Study of Linear Accelerator–Based Virtual Brachytherapy (BOOSTER) for Prostate Cancer; Virtual HDR Brachytherapy for Prostate Cancer
por: Eade, Thomas, et al.
Publicado: (2019)

Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy
por: Liu, Yuan, et al.
Publicado: (2020)

Brachytherapy for Prostate Cancer: A Systematic Review
por: Koukourakis, Georgios, et al.
Publicado: (2009)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

Racial and socioeconomic disparities in the selection of prostate brachytherapy
por: Schreiber, David, et al.
Publicado: (2013)

Brachytherapy in the therapy of prostate cancer – an interesting choice
por: Skowronek, Janusz
Publicado: (2013)

AB012. Brachytherapy for localized prostate cancer
por: Xu, Yong, et al.
Publicado: (2016)

Influence of zonal dosimetry on prostate brachytherapy outcomes
por: Hong, Cheng William, et al.
Publicado: (2015)

Prostate brachytherapy in Ghana: our initial experience
por: Mensah, James Edward, et al.
Publicado: (2016)

Perineal recurrence of prostate cancer post-brachytherapy
por: Cooper, Sian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_csjdkgbek7viqfutnklpks5qj4